<p>Cochlear Limited 非赞助 ADR (OTCMKTS:CHEOY - 获取免费报告) 在 12 月份经历了显著的空头头寸下降。截至 12 月 15 日，空头头寸总计为 2,538 股，比 11 月 30 日的 6,974 股下降了 63.6%。根据平均每日交易量 33,732 股，目前的空头头寸比率为 0.1 天。公司约 0.0% 的股票被卖空。</p>
<h2>分析师评级变动</h2>
<p>CHEOY 已成为多份分析师报告的主题。Canaccord Genuity Group 在 10 月 7 日的研究报告中将 Cochlear 的评级从 “持有” 上调至 “强力买入”。花旗集团在 9 月 18 日的研究报告中将 Cochlear 的评级下调至 “中性”。两位分析师给予该股票 “强力买入” 评级，三位分析师给予公司 “持有” 评级。根据 MarketBeat 的数据，Cochlear 目前的共识评级为 “适度买入”。</p>
<p><strong>阅读我们关于 Cochlear 的最新股票报告</strong></p>
<h2>Cochlear 股价上涨 0.5%</h2>
<p>CHEOY 的股票在周五以 $88.01 开盘。该公司的 50 日简单移动平均线为 $90.51，200 日简单移动平均线为 $94.86。Cochlear 的 12 个月低点为 $74.76，12 个月高点为 $105.60。</p>
<h2>关于 Cochlear</h2>
<p>(获取免费报告)</p>
<p>Cochlear Limited 为全球儿童和成人提供可植入的听力解决方案。它提供耳蜗植入系统、声音处理器升级、骨导系统、配件及其他产品。Cochlear Limited 成立于 1981 年，总部位于澳大利亚悉尼。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票比 Cochlear 更好</li>
<li>华盛顿为战争做准备</li>
<li>将你的 “死钱” 转变为每月 306 美元以上（从这个月开始）</li>
<li>在美国鬼城发现 100 万亿美元的 “人工智能金属”</li>
<li>在 1 月 1 日之前将 1000 美元投入这只股票 [不是 NVDA]</li>
<li>特朗普为何杀死美国便士的可怕原因？</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 在 Cochlear 吗？</h2>
<p>在考虑 Cochlear 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Cochlear 并不在名单上。</p>
<p>虽然 Cochlear 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

CHEOY

<p>Cochlear Limited 未赞助的 ADR (OTCMKTS:CHEOY) 在 12 月份的空头头寸显著下降，减少了 63.6%，降至 2,538 股。空头头寸比率现在为 0.1 天。分析师的评级各不相同，有些将评级上调至 “强烈买入”，而其他则维持 “持有”。该股票的交易价格为 88.01 美元，12 个月的价格区间为 74.76 美元至 105.60 美元。Cochlear 在全球提供可植入的听力解决方案，总部位于澳大利亚悉尼</p>

<p>CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report) was the recipient of a significant drop in short interest during the month of December. As of December 15th, there was short interest totaling 2,538 shares, a drop of 63.6% from the November 30th total of 6,974 shares. Based on an average daily volume of 33,732 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company's stock are sold short. Approximately 0.0% of the company's stock are sold short. Based on an average daily volume of 33,732 shares, the short-interest ratio is currently 0.1 days.</p>
<div class="lb-trans"><p>Cochlear Limited 非赞助 ADR (OTCMKTS:CHEOY - 获取免费报告) 在 12 月份经历了显著的空头头寸下降。截至 12 月 15 日，空头头寸总计为 2,538 股，比 11 月 30 日的 6,974 股下降了 63.6%。根据平均每日交易量 33,732 股，目前的空头头寸比率为 0.1 天。公司约 0.0% 的股票被卖空。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>CHEOY has been the subject of a number of analyst reports. Canaccord Genuity Group raised CochLear from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Tuesday, October 7th. Citigroup cut CochLear to a &#34;neutral&#34; rating in a research note on Thursday, September 18th. Two analysts have rated the stock with a Strong Buy rating and three have given a Hold rating to the company. According to MarketBeat, CochLear currently has a consensus rating of &#34;Moderate Buy&#34;.</p>
<div class="lb-trans"><p>CHEOY 已成为多份分析师报告的主题。Canaccord Genuity Group 在 10 月 7 日的研究报告中将 Cochlear 的评级从 “持有” 上调至 “强力买入”。花旗集团在 9 月 18 日的研究报告中将 Cochlear 的评级下调至 “中性”。两位分析师给予该股票 “强力买入” 评级，三位分析师给予公司 “持有” 评级。根据 MarketBeat 的数据，Cochlear 目前的共识评级为 “适度买入”。</p>
</div><p><strong>Read Our Latest Stock Report on CochLear</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 Cochlear 的最新股票报告</strong></p>
</div><h2>CochLear Trading Up 0.5%</h2>
<div class="lb-trans"><h2>Cochlear 股价上涨 0.5%</h2>
</div><p>Shares of CHEOY opened at $88.01 on Friday. The business's fifty day simple moving average is $90.51 and its two-hundred day simple moving average is $94.86. CochLear has a 12 month low of $74.76 and a 12 month high of $105.60.</p>
<div class="lb-trans"><p>CHEOY 的股票在周五以 $88.01 开盘。该公司的 50 日简单移动平均线为 $90.51，200 日简单移动平均线为 $94.86。Cochlear 的 12 个月低点为 $74.76，12 个月高点为 $105.60。</p>
</div><h2>About CochLear</h2>
<div class="lb-trans"><h2>关于 Cochlear</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.</p>
<div class="lb-trans"><p>Cochlear Limited 为全球儿童和成人提供可植入的听力解决方案。它提供耳蜗植入系统、声音处理器升级、骨导系统、配件及其他产品。Cochlear Limited 成立于 1981 年，总部位于澳大利亚悉尼。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than CochLear</li>
<li>Washington prepares for war</li>
<li>Turn your &#34;dead money&#34; into $306+ monthly (starting this month)</li>
<li>$100 Trillion “AI Metal” Found in American Ghost Town</li>
<li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li>
<li>Terrifying reason Trump killed the U.S. penny?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 Cochlear 更好</li>
<li>华盛顿为战争做准备</li>
<li>将你的 “死钱” 转变为每月 306 美元以上（从这个月开始）</li>
<li>在美国鬼城发现 100 万亿美元的 “人工智能金属”</li>
<li>在 1 月 1 日之前将 1000 美元投入这只股票 [不是 NVDA]</li>
<li>特朗普为何杀死美国便士的可怕原因？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in CochLear Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Cochlear 吗？</h2>
</div><p>Before you consider CochLear, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cochlear 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Cochlear 并不在名单上。</p>
</div><p>While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Cochlear 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Cochlear Limited 非赞助 ADR（OTCMKTS:CHEOY）的空头头寸在 12 月份下降了 63.6%